Medicine recalls
|
| |
| The United States: Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of Adulteration |
| |
The U.S. Food & Drug Administration (FDA) reported that Westminster Pharmaceuticals, LLC is voluntarily recalling all lots, within expiry, of Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 mg, 60 mg, 90 mg, & 120 mg to the wholesale level.
These products are being recalled as a precaution because they were manufactured using active pharmaceutical ingredients that were sourced prior to the FDA’s Import Alert of Sichuan Friendly Pharmaceutical Co., Ltd., which as a result of a 2017 inspection were found to have deficiencies with Current Good Manufacturing Practices (cGMP). Substandard cGMP practices could represent the possibility of risk being introduced into the manufacturing process.
To date, Westminster Pharmaceuticals has not received any reports of adverse events related to this product.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/Recalls/ucm616601.htm
In Hong Kong, the above product is not registered pharmaceutical product.
Ends/ Saturday, August 11, 2018
Issued at HKT 12:00
|
| |
